Hetero Research Foundation, based in Hyderabad, Telangana, specializes in the research and development of innovative pharmaceutical solutions. The organization focuses on a range of therapeutic areas, particularly in the fields of oncology and infectious diseases, with notable expertise in compounds such as Pomalidomide, Lomitapide, and Dolutegravir. By advancing drug development and manufacturing processes, Hetero aims to enhance treatment options for patients globally, particularly in the areas of HIV and cancer management.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

49 Patents

#5 in Hyderabad Telangana

#40 in India

#14,277 in the World

Hyderabad Telangana, India

Hetero Research Foundation

Forward Citations = 33

31 inventors:

Bandi Parthasaradhi Reddy (49 out of 96 patents)

Kura Rathnakar Reddy (43 out of 94 patents)

Dasari Muralidhara Reddy (38 out of 73 patents)

4. Bandi Vamsi Krishna (34 out of 42 patents)

5. Rapolu Raji Reddy (19 out of 50 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Hetero Research Foundation. Retrieved from https://idiyas.com/company/hetero-research-foundation

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

29 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]